Evotec AG and the Jain Foundation have extended and expanded their research collaboration using Evotec’s assay development and screening capabilities to support the Jain Foundation’s research efforts to find a cure for dysferlinopathy. Financial details were not disclosed.   Dr. Mario Polywka, chief operating officer of Evotec, said, “We look forward to our continued collaboration with the Jain Foundation on this project. This collaboration highlights both the increasing role t...